BECAIT

BECAIT

Bezafibrate Coronary Atherosclerosis Intervention Trial. A trial assessing the ability of a lipid-altering agent, bezafibrate, to retard the development of coronary lesions.
 
Conclusion
Long-term use of bezafibrate slows the progression of coronary atheromas and coronary events in young male survivors of acute myocardial infarction.
References in periodicals archive ?
e's in ost nto ing led way manause "It's quite rare becait's got all these 'extras' it," said Edward, the owof Candle Lane Bookshrewsbury.
Fibrate therapy can reduce CAD risk and slow plaque progression in patients with low HDL levels, as shown in the Helsinki Heart Study and the Lopid Coronary Angiographic Trial (LOCAT), Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT), and Veterans Affairs High Density Lipoprotein Cholesterol Intervention Trial study group (VA-HIT).